Manufacturing, Parenterals and Injectables

Evonik Qualifies Filling Line for Parenteral Drug Products at its Alabama Facility

September 09, 2020

The new line has the ability to aseptically fill powder, liquid, suspension, and combination forms into vials in clinical or commercial batch sizes.

Alcami to Provide Manufacturing Services for Trevena’s Pain Management Injection

September 03, 2020

Alcami will provide services for Trevena’s OLINVYK (oliceridine) injection, an opioid approved for the management of acute pain severe enough to require an intravenous opioid analgesic in adults.

Robotic Inspection System Improves Accuracy

July 09, 2020

Stevanato Group’s Vision Robot Unit uses AI-based machine learning capabilities for particle and cosmetic inspection of biopharmaceutical drug products.

Grand River Aseptic Manufacturing Opens Large-Scale Injectable Fill/Finish Facility

July 02, 2020

The new facility in Grand Rapids, MI, is part of the CDMO’s aggressive expansion plan.

SiO2 Scales Up Container Technology for COVID-19 Vaccines and Treatments

June 08, 2020

SiO2 Materials Science has received $143 million from the US government to accelerate capacity scale-up of its advanced primary packaging platform.

PharmTech Sponsored eBooks

Complications in Process Simulation Execution

June 01, 2020

Regulators have exaggerated expectations for simulated media fills.

Wavelength Pharmaceuticals Expands Supplies of Drug Ingredients for Managing COVID-19 and Adds API CDMO Services

April 23, 2020

Wavelength Pharmaceuticals expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients in the COVID-19 pandemic.

Addressing Drug Shortages

April 02, 2020

Civica Rx plans redundant manufacturing capacity to relieve and prevent shortages of generic, sterile injectable drugs.

FDA and EMA Accept Biologics Application for Novartis Multiple Sclerosis Cell Therapy

February 27, 2020

If approved, the therapy may become the first-choice treatment for relapsing multiple sclerosis patients and will be the first B-cell therapy that can be self-administered using an autoinjector pen.

Schott to Present New Syringe Format at Pharmapack 2020

February 06, 2020

The company will showcase the syriQ BioPure syringe in a 2.25-mL format for autoinjectors at Pharmapack in Paris, France from Feb. 5¬¬–6, 2020.